Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.70
+0.10 (0.33%)
At close: Jan 22, 2026
27.65%
Market Cap1.12B
Revenue (ttm)798.27M
Net Income (ttm)-10.94M
Shares Out36.61M
EPS (ttm)-0.30
PE Ration/a
Forward PEn/a
Dividend0.25 (0.82%)
Ex-Dividend Daten/a
Volume90
Average Volume16,955
Open30.00
Previous Close30.60
Day's Range30.00 - 30.70
52-Week Range18.50 - 35.85
Beta1.06
RSI49.82
Earnings DateMar 26, 2026

About Prince Pharmaceutical

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince ... [Read more]

Sector Healthcare
Founded 1962
Employees 210
Stock Exchange Taipei Exchange
Ticker Symbol 6935
Full Company Profile

Financial Performance

Financial Statements